University of Michigan Research Offices

The A. Alfred Taubman Medical Research Institute, established in 2008 by philanthropist A. Alfred Taubman, is a leading research institution at the University of Michigan dedicated to advancing the understanding, treatment, and prevention of various diseases affecting humanity. With a focus on fundamental scientific discovery, the institute aims to alleviate suffering through innovative research initiatives and collaboration among scientific teams. Generated from the website

EVOQ Therapeutics LLC, based in Ann Arbor, Michigan, is at the forefront of developing innovative immunotherapies aimed at enhancing the lives of individuals suffering from autoimmune diseases. Utilizing their proprietary NanoDisc technology, the company targets the root causes of conditions such as Type 1 diabetes, Celiac disease, and Lupus by restoring the body's native immune tolerance. Through simple subcutaneous administration, EVOQ's NanoDiscs deliver disease-specific antigens directly to critical immune cells, significantly improving immune responses with up to 30 times greater effectiveness compared to traditional therapies. Their promising preclinical data indicates a new direction for treating autoimmune diseases, emphasizing targeted delivery and enhanced patient outcomes. Generated from the website